Dr Koen Pouwels
Contact information
Koen Pouwels
Phd
Senior Researcher
Koen joined Oxford Population Health's Health Economics Research Centre (HERC) as a senior researcher in January 2019. His current work focuses on infectious disease and antimicrobial resistance modelling, randomised trial designs, economic evaluations alongside trials, incorporating long-term effects into economic evaluations, and statistical approaches to address time-dependent confounding in burden of illness studies.
His work has directly informed national COVID-19 mitigation and testing strategies, vaccination policies against various infectious diseases, as well as national targets for antibiotic prescribing in primary care.
Prior to joining HERC, Koen worked at Public Health England on projects using mathematical, statistical and machine learning approaches to understand and predict the development and health-economic impact of healthcare associated infections and antimicrobial resistance. Before coming to the UK, he obtained his PhD in epidemiology at the University of Groningen where he was also involved in a number of economic evaluations of vaccinations against infectious diseases.
Recent publications
-
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Preprint
Pouwels KB. et al, (2023)
-
Implementing antibiotic stewardship in high prescribing English general practices: a mixed-methods study
Journal article
TONKIN-CRINE S. et al, (2023), British Journal of General Practice
-
An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence
Journal article
Morvan M. et al, (2022), Nature Communications, 13
-
Estimation of the impact of hospital-onset SARS-CoV-2 infections on length of stay in English hospitals using causal inference
Journal article
POUWELS K. and Ben C., (2022), BMC Infectious Diseases
-
Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study.
Journal article
Ayoubkhani D. et al, (2022), Open Forum Infect Dis, 9